NATIMAB THERAPEUTICS
NatiMab Therapeutics identifies and develops human antibodies (Abs) for the therapy and diagnosis of infectious diseases and cancer. NatiMab Therapeutics is an Italian SME located in the premises of the Bioindustry Park Canavese scientific and technological park, at Colleretto Giacosa (Torino). Registered on 02/01/2008 in Torino, NatiMab was founded by Gianni Garotta, Maurizio Denaro, Marianne Murphy and Gerritt Hagens. On 10/12/2014, two previously key collaborators, Francesco Novelli and Guido Forni joined the company as shareholders.
NATIMAB THERAPEUTICS
Industry:
Biotechnology Health Care Wellness
Founded:
2008-01-01
Address:
Metropolitan, Michigan, United States
Country:
United States
Website Url:
http://www.natimab.com
Total Employee:
11+
Status:
Active
Total Funding:
50 K EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Font Awesome Domain Not Resolving Apache Google Maps Google Maps API
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Pandion Therapeutics
Pandion Therapeutics develops innovative modular proteins, antibodies, and bispecifics for autoimmune and inflammatory diseases.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - NatiMab Therapeutics
Official Site Inspections
http://www.natimab.com
- Host name: 38.11.76.105
- IP address: 38.11.76.105
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
